BioNeutra Global Corporation
BGACF
$0.067
$0.006911.48%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.98M | 7.63M | 8.05M | 8.44M | 8.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.98M | 7.63M | 8.05M | 8.44M | 8.35M |
| Cost of Revenue | 4.56M | 4.17M | 4.89M | 5.38M | 7.47M |
| Gross Profit | 3.42M | 3.47M | 3.16M | 3.06M | 887.00K |
| SG&A Expenses | 3.78M | 3.86M | 3.63M | 3.61M | 3.64M |
| Depreciation & Amortization | 154.10K | 156.80K | 168.20K | 168.20K | 192.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.57M | 8.28M | 8.80M | 9.26M | 11.42M |
| Operating Income | -593.00K | -649.50K | -754.20K | -825.00K | -3.07M |
| Income Before Tax | -450.10K | -1.14M | -1.51M | -1.58M | -3.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.45 | -1.14 | -1.51 | -1.58 | -3.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -450.10K | -1.14M | -1.51M | -1.58M | -3.49M |
| EBIT | -593.00K | -649.50K | -754.20K | -825.00K | -3.07M |
| EBITDA | -15.30K | 96.00K | 8.50K | -41.10K | -2.32M |
| EPS Basic | -0.01 | -0.02 | -0.03 | -0.03 | -0.08 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.04 |
| EPS Diluted | -0.02 | -0.04 | -0.04 | -0.04 | -0.08 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.04 |
| Average Basic Shares Outstanding | 185.05M | 185.05M | 185.05M | 185.05M | 185.80M |
| Average Diluted Shares Outstanding | 185.05M | 185.05M | 185.05M | 185.05M | 185.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
